LIVN Q1 2026 Earnings EPS Beats Estimates by 714 as Margins Drive Surprise GT Biopharma Q1 2026 Earnings WiderthanExpected Loss Amid Continued Development C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution Sachem Capital SACH Q4 2025 Earnings EPS Surges 782 Above Estimates Shares Decline Despite Strong Bottom Line Alta Equipment Group Q1 2026 Earnings EPS Falls Short of Estimates as Operational Headwinds Persist LFST Q1 2026 Earnings A Massive EPS Surprise Overshadowed by Market Skepticism